Aquatic Capital Management LLC Cuts Stake in McKesson Co. (NYSE:MCK)

Aquatic Capital Management LLC cut its stake in McKesson Co. (NYSE:MCK - Free Report) by 52.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 21,000 shares of the company's stock after selling 23,480 shares during the quarter. Aquatic Capital Management LLC's holdings in McKesson were worth $11,968,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of MCK. Millstone Evans Group LLC acquired a new position in shares of McKesson during the 4th quarter worth approximately $28,000. Synergy Asset Management LLC acquired a new position in shares of McKesson during the 4th quarter worth approximately $32,000. Crews Bank & Trust acquired a new position in shares of McKesson during the 4th quarter worth approximately $33,000. Atala Financial Inc acquired a new position in shares of McKesson during the 4th quarter worth approximately $34,000. Finally, Graney & King LLC acquired a new position in shares of McKesson during the 4th quarter worth approximately $38,000. 85.07% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, CEO Brian S. Tyler sold 8,961 shares of the company's stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the sale, the chief executive officer now directly owns 60,664 shares of the company's stock, valued at $36,276,465.36. This represents a 12.87 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Leann B. Smith sold 188 shares of the company's stock in a transaction that occurred on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total transaction of $114,602.92. Following the sale, the executive vice president now directly owns 1,051 shares in the company, valued at approximately $640,679.09. The trade was a 15.17 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 18,110 shares of company stock valued at $10,855,706. Company insiders own 0.11% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on MCK shares. UBS Group upped their target price on McKesson from $708.00 to $805.00 and gave the stock a "buy" rating in a research note on Tuesday. Cfra Research lowered McKesson from a "moderate buy" rating to a "hold" rating in a report on Friday, April 4th. Mizuho upped their target price on shares of McKesson from $630.00 to $690.00 and gave the stock a "neutral" rating in a report on Thursday, April 3rd. Bank of America raised their price target on shares of McKesson from $665.00 to $755.00 and gave the stock a "buy" rating in a research note on Friday, April 11th. Finally, Citigroup lowered their price target on shares of McKesson from $713.00 to $677.00 and set a "buy" rating on the stock in a research report on Friday, January 10th. Three investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $681.00.

McKesson Stock Up 1.1 %

NYSE:MCK traded up $7.95 on Tuesday, hitting $707.68. The stock had a trading volume of 567,405 shares, compared to its average volume of 889,984. The stock has a market cap of $88.69 billion, a price-to-earnings ratio of 32.40, a PEG ratio of 1.29 and a beta of 0.49. The company has a fifty day moving average price of $663.22 and a two-hundred day moving average price of $609.22. McKesson Co. has a 1-year low of $464.42 and a 1-year high of $728.32.

McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. As a group, analysts anticipate that McKesson Co. will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd were paid a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.40%. The ex-dividend date of this dividend was Monday, March 3rd. McKesson's dividend payout ratio (DPR) is 13.00%.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.